Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
24 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to DBV Technologies S.A.’s names, not what it holds today.
Patents granted
24
18 utility, 6 design, 1976 to Dec 31, 2025
Granted in 2025
4
Against 4 in 2024 and 2 in 2023
Applications published
25
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'10'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
DBV TECHNOLOGIES its own name
FR, as the owner printed on each patent
24 granted
16 publishedDBV TECHNOLOGIES its own name
named as the applicant on its applications, in FR
0 granted
9 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 30, 2025 | 12,508,608 | Method of depositing a substance on a substrate | Pharmaceuticals | DBV TECHNOLOGIES |
| Sep 2, 2025 | 12,403,193 | Allergen desensitization method | Pharmaceuticals | DBV TECHNOLOGIES |
| May 20, 2025 | D1,076,111 | Patch assembly | | DBV TECHNOLOGIES |
| May 20, 2025 | D1,076,110 | Patch assembly | | DBV TECHNOLOGIES |
| Mar 26, 2024 | 11,938,178 | Optimized epicutaneous vaccination | Pharmaceuticals | DBV TECHNOLOGIES |
| Mar 19, 2024 | 11,931,411 | Allergen desensitization method | Pharmaceuticals | DBV TECHNOLOGIES |
| Jan 23, 2024 | D1,012,297 | Patch assembly | | DBV TECHNOLOGIES |
| Jan 23, 2024 | D1,012,296 | Patch assembly | | DBV TECHNOLOGIES |
| Sep 19, 2023 | D999,385 | Patch assembly | | DBV TECHNOLOGIES |
| Sep 19, 2023 | D999,384 | Patch assembly | | DBV TECHNOLOGIES |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 11, 2025 | 2025/0375518 | ALLERGEN DESENSITIZATION METHOD | Pharmaceuticals | DBV TECHNOLOGIES |
| Dec 12, 2024 | 2024/0408364 | Improved patches and methods for delivering an active substance to the skin using the same | Medical technology | DBV TECHNOLOGIES |
| Oct 17, 2024 | 2024/0342273 | IMMUNOTHERAPEUTIC METHOD FOR INCREASING CASHEW TOLERANCE IN A SUBJECT | Pharmaceuticals | DBV TECHNOLOGIES |
| Aug 8, 2024 | 2024/0261385 | OPTIMIZED EPICUTANEOUS VACCINATION | Pharmaceuticals | DBV TECHNOLOGIES |
| Jun 6, 2024 | 2024/0181046 | ALLERGEN DESENSITIZATION METHOD | Pharmaceuticals | DBV TECHNOLOGIES · patent 12,403,193 granted from it |
| Nov 9, 2023 | 2023/0355737 | PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION | Pharmaceuticals | DBV TECHNOLOGIES |
| Dec 29, 2022 | 2022/0410188 | METHOD OF DEPOSITING A SUBSTANCE ON A SUBSTRATE | Organic fine chemistry | DBV TECHNOLOGIES · patent 12,508,608 granted from it |
| Aug 4, 2022 | 2022/0241405 | ALLERGEN DESENSITIZATION METHOD | Pharmaceuticals | DBV TECHNOLOGIES · patent 11,931,411 granted from it |
| Apr 29, 2021 | 2021/0121556 | OPTIMIZED EPICUTANEOUS VACCINATION | Pharmaceuticals | DBV TECHNOLOGIES · patent 11,938,178 granted from it |
| Nov 12, 2020 | 2020/0353072 | ALLERGEN DESENSITIZATION METHOD | Pharmaceuticals | DBV TECHNOLOGIES · patent 11,202,826 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 4 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.